🚀 VC round data is live in beta, check it out!
OTC Markets Valuation Multiples
Discover revenue and EBITDA valuation multiples for OTC Markets and similar public comparables like Johannesburg Stock Exchange, Athens Exchange Group, Warsaw Stock Exchange, Philippine Stock Exchange and more.
OTC Markets Overview
About OTC Markets
OTC Markets Group Inc operates financial markets for securities in the U.S. and globally. The firm mainly operates OTCQX best market, OTCQB venture market and Pink open market. It has OTC link ATS, market data licensing and corporate services business lines. The activities of these business lines encompass quotation and trade messaging services, network-based platform, access to market data, a suite of market data licenses and disclosure and information services. It derives a majority of its revenue from the U.S.
Founded
1997
HQ
Employees
133
Website
Sectors
Financials (LTM)
EV
$618M
OTC Markets Financials
OTC Markets reported last 12-month revenue of $123M and EBITDA of $48M.
In the same LTM period, OTC Markets generated $48M in EBITDA and $32M in net income.
Revenue (LTM)
OTC Markets P&L
In the most recent fiscal year, OTC Markets reported revenue of $125M and EBITDA of $48M.
OTC Markets expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $123M | XXX | $125M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $66M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 52% | XXX | XXX | XXX |
| EBITDA | $48M | XXX | $48M | XXX | XXX | XXX |
| EBITDA Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBIT Margin | 32% | XXX | 31% | XXX | XXX | XXX |
| Net Profit | $32M | XXX | $31M | XXX | XXX | XXX |
| Net Margin | 26% | XXX | 25% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
OTC Markets Stock Performance
OTC Markets has current market cap of $661M, and enterprise value of $618M.
Market Cap Evolution
OTC Markets' stock price is $54.95.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $618M | $661M | 0.0% | XXX | XXX | XXX | $2.59 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOTC Markets Valuation Multiples
OTC Markets trades at 5.0x EV/Revenue multiple, and 12.8x EV/EBITDA.
EV / Revenue (LTM)
OTC Markets Financial Valuation Multiples
As of April 20, 2026, OTC Markets has market cap of $661M and EV of $618M.
Equity research analysts estimate OTC Markets' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
OTC Markets has a P/E ratio of 20.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $661M | XXX | $661M | XXX | XXX | XXX |
| EV (current) | $618M | XXX | $618M | XXX | XXX | XXX |
| EV/Revenue | 5.0x | XXX | 4.9x | XXX | XXX | XXX |
| EV/EBITDA | 12.8x | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBIT | 15.8x | XXX | 16.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 9.4x | XXX | XXX | XXX |
| P/E | 20.7x | XXX | 21.2x | XXX | XXX | XXX |
| EV/FCF | 17.5x | XXX | 12.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified OTC Markets Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
OTC Markets Margins & Growth Rates
OTC Markets' revenue in the last 12 month grew by 5%.
OTC Markets' revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.
OTC Markets' rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OTC Markets' rule of X is 44% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
OTC Markets Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 41% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 44% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | 9% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
OTC Markets Public Comps
See public comps and valuation multiples for other Stock Exchanges comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| OTC Markets | XXX | XXX | XXX | XXX | XXX | XXX |
| Johannesburg Stock Exchange | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Exchange Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Warsaw Stock Exchange | XXX | XXX | XXX | XXX | XXX | XXX |
| Philippine Stock Exchange | XXX | XXX | XXX | XXX | XXX | XXX |
| NZX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OTC Markets M&A Activity
OTC Markets acquired XXX companies to date.
Last acquisition by OTC Markets was on XXXXXXXX, XXXXX. OTC Markets acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by OTC Markets
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialOTC Markets Investment Activity
OTC Markets invested in XXX companies to date.
OTC Markets made its latest investment on XXXXXXXX, XXXXX. OTC Markets invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by OTC Markets
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout OTC Markets
| When was OTC Markets founded? | OTC Markets was founded in 1997. |
| Where is OTC Markets headquartered? | OTC Markets is headquartered in United States. |
| How many employees does OTC Markets have? | As of today, OTC Markets has over 133 employees. |
| Is OTC Markets publicly listed? | Yes, OTC Markets is a public company listed on OTC Pink Sheets. |
| What is the stock symbol of OTC Markets? | OTC Markets trades under OTCM ticker. |
| Who are competitors of OTC Markets? | OTC Markets main competitors are Johannesburg Stock Exchange, Athens Exchange Group, Warsaw Stock Exchange, Philippine Stock Exchange. |
| What is the current market cap of OTC Markets? | OTC Markets' current market cap is $661M. |
| What is the current revenue of OTC Markets? | OTC Markets' last 12 months revenue is $123M. |
| What is the current revenue growth of OTC Markets? | OTC Markets revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of OTC Markets? | Current revenue multiple of OTC Markets is 5.0x. |
| Is OTC Markets profitable? | Yes, OTC Markets is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of OTC Markets? | OTC Markets' last 12 months EBITDA is $48M. |
| What is OTC Markets' EBITDA margin? | OTC Markets' last 12 months EBITDA margin is 39%. |
| What is the current EV/EBITDA multiple of OTC Markets? | Current EBITDA multiple of OTC Markets is 12.8x. |
| What is the current FCF of OTC Markets? | OTC Markets' last 12 months FCF is $35M. |
| What is OTC Markets' FCF margin? | OTC Markets' last 12 months FCF margin is 29%. |
| What is the current EV/FCF multiple of OTC Markets? | Current FCF multiple of OTC Markets is 17.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.